These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21130668)

  • 1. Moyamoya syndrome associated with Graves' disease: a case report and review of the literature.
    Malik S; Russman AN; Katramados AM; Silver B; Mitsias PD
    J Stroke Cerebrovasc Dis; 2011 Nov; 20(6):528-36. PubMed ID: 21130668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moyamoya disease complicated by Graves' disease and type 2 diabetes mellitus: report of two cases.
    Suzuki S; Mitsuyama T; Horiba A; Fukushima S; Hashimoto N; Kawamata T
    Clin Neurol Neurosurg; 2011 May; 113(4):325-9. PubMed ID: 21215511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurologic improvement without angiographic improvement after antithyroid therapy in a patient with Moyamoya syndrome.
    Ishigami A; Toyoda K; Suzuki R; Miyashita F; Iihara K; Minematsu K
    J Stroke Cerebrovasc Dis; 2014; 23(5):1256-8. PubMed ID: 24119625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent Graves' disease and intracranial arterial stenosis/occlusion: special considerations regarding the state of thyroid function, etiology, and treatment.
    Ohba S; Nakagawa T; Murakami H
    Neurosurg Rev; 2011 Jul; 34(3):297-304; discussion 304. PubMed ID: 21424208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moyamoya Disease Associated with Graves' Disease and Down Syndrome: A Case Report and Literature Review.
    Nakamura H; Sato K; Yoshimura S; Hayashi Y; Izumo T; Tokunaga Y
    J Stroke Cerebrovasc Dis; 2021 Jan; 30(1):105414. PubMed ID: 33130479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent moyamoya disease and Graves' thyrotoxicosis: case report and literature review.
    Shen AL; Ryu SJ; Lin SK
    Acta Neurol Taiwan; 2006 Jun; 15(2):114-9. PubMed ID: 16871899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion.
    Hayashi T; Shirane R; Fujimura M; Tominaga T
    J Neurosurg Pediatr; 2010 Jul; 6(1):73-81. PubMed ID: 20593991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial moyamoya disease associated with Graves' disease in a mother and daughter. Two case reports.
    Tokimura H; Tajitsu K; Takashima H; Hirayama T; Tsuchiya M; Takayama K; Arita K
    Neurol Med Chir (Tokyo); 2010; 50(8):668-74. PubMed ID: 20805652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexistence of moyamoya and Graves' diseases: the clinical characteristics and treatment effects of 21 Chinese patients.
    Li D; Yang W; Xian P; Liu P; Bao X; Zong R; Duan L
    Clin Neurol Neurosurg; 2013 Sep; 115(9):1647-52. PubMed ID: 23518423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graves' disease in children and adolescents: response to long-term treatment.
    Barrio R; López-Capapé M; Martinez-Badás I; Carrillo A; Moreno JC; Alonso M
    Acta Paediatr; 2005 Nov; 94(11):1583-9. PubMed ID: 16303698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfusion-weighted magnetic resonance imaging in adult moyamoya syndrome: characteristic patterns and change after surgical intervention: case report.
    Wityk RJ; Hillis A; Beauchamp N; Barker PB; Rigamonti D
    Neurosurgery; 2002 Dec; 51(6):1499-505; discussion 1506. PubMed ID: 12445358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The surgical treatment of Graves' disease].
    de Ruijter SH; van Dalen T; Muller AF
    Ned Tijdschr Geneeskd; 2006 Jun; 150(24):1321-5. PubMed ID: 16808361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrence of Graves' disease and dysplastic cerebral blood vessels of the moyamoya variety.
    Tendler BE; Shoukri K; Malchoff C; MacGillivray D; Duckrow R; Talmadge T; Ramsby GR
    Thyroid; 1997 Aug; 7(4):625-9. PubMed ID: 9292953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 10-year-old girl with coexistent moyamoya disease and Graves' disease.
    Golomb MR; Biller J; Smith JL; Edwards-Brown M; Sanchez JC; Nebesio TD; Garg BP
    J Child Neurol; 2005 Jul; 20(7):620-4. PubMed ID: 16159534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcome of Graves' disease in Thai children.
    Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
    J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moyamoya disease associated with Graves disease: special considerations regarding clinical significance and management.
    Im SH; Oh CW; Kwon OK; Kim JE; Han DH
    J Neurosurg; 2005 Jun; 102(6):1013-7. PubMed ID: 16028759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperthyroidism: diagnosis and management of Graves' disease.
    Schilling JS
    Nurse Pract; 1997 Jun; 22(6):72, 75, 78 passim; quiz 96-7. PubMed ID: 9211454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic Moyamoya disease: clinical features and outcome after indirect bypass surgery in four French adults.
    Derex L; Doumbé J; Kouamé-Assouan AE; Pelissou-Guyotat I; Morel C; Hermier M; Nighoghossian N; Trouillas P
    J Neurol Sci; 2010 Jan; 288(1-2):92-5. PubMed ID: 19840882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moyamoya syndrome with protein S deficiency.
    Akgün D; YiLmaz S; Senbil N; Aslan B; Gürer YY
    Eur J Paediatr Neurol; 2000; 4(4):185-8. PubMed ID: 11008263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
    Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.